Drugs / Prochloroperazine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05586763 Comparator | Feb 2022 → Dec 2024 | peripheral vertigo | Oman Medical Speciality Board | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prochloroperazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05586763 ↗ |
| Route | Intramuscular | “IM prochloraperazine 12.5mg” NCT05586763 ↗ |